Precigen (PGEN) Cost of Revenue (2013 - 2026)

Precigen (PGEN) has reported Cost of Revenue for 14 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 156.87% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $8.0 million, a 82.95% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 13.03% from the prior year.
• Cost of Revenue was $2.8 million for Q2 2026 at Precigen, up from $2.6 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $2.8 million in Q2 2026 and troughed at $1.0 million in Q3 2024.
• A 5-year average of $1.5 million and a median of $1.4 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue slumped 77.11% in 2022 and jumped 156.87% in 2026, its largest moves.
• Over 5 years, Cost of Revenue stood at $1.3 million in 2022, then climbed by 8.04% to $1.4 million in 2023, then dropped by 13.92% to $1.2 million in 2024, then soared by 36.53% to $1.6 million in 2025, then surged by 75.75% to $2.8 million in 2026.
• The last three Cost of Revenue figures came in at $2.8 million (Q2 2026), $2.6 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.